|本期目录/Table of Contents|

[1]盛正成综述,周文泉审校.上尿路上皮癌的手术治疗进展[J].医学研究与战创伤救治(原医学研究生学报),2020,22(4):399-402.[doi:10.3969/j.issn.1672-271X.2020.04.014]
　SHENG Zheng-cheng reviewing,ZHOU Wen-quan checking.Progress in surgical treatment of upper urinary tract carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(4):399-402.[doi:10.3969/j.issn.1672-271X.2020.04.014]
点击复制

上尿路上皮癌的手术治疗进展()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第22卷
期数:
2020年4期
页码:
399-402
栏目:
综述
出版日期:
2020-07-20

文章信息/Info

Title:
Progress in surgical treatment of upper urinary tract carcinoma
作者:
盛正成综述; 周文泉审校
作者单位：210002 南京，南京医科大学附属金陵临床医学院（东部战区总医院）泌尿外科(盛正成、周文泉)
Author(s):
SHENG Zheng-cheng reviewing;  ZHOU Wen-quan checking
(Department of Urology, Jinling Clinical Medical College Affiliated to Nanjing Medical University/General Hospital of Eastern Theater Command, PLA, Nanjing 210002, Jiangsu, China)
关键词:
尿路上皮癌; 保肾手术; 根治性肾输尿管除术; 系统性治疗
Keywords:
urothelial carcinoma;  kidney-sparing surgery;  radical nephroureterectomy;  systematic treatment
分类号:
R699
DOI:
10.3969/j.issn.1672-271X.2020.04.014
文献标志码:
A
摘要:
尿路上皮癌是常见的实体恶性肿瘤，大多数病例(90%~95%)发生在下尿路(膀胱和尿道)，其余病例发生在上尿路(肾盏、肾盂和输尿管)。相比下尿路上皮癌，目前对上尿路上皮癌(UTUC)的认识尚不全面，尤其是手术治疗方案的选择。文章主要通过低级别肿瘤的保肾手术、高级别肿瘤的根治性肾输尿管除术以及转移性肿瘤的姑息手术等对UTUC的手术治疗进行综述。
Abstract:
Urothelial cancer is a common solid malignant tumor, with a majority of cases (90% to 95%) occurring in the lower urinary tract (bladder and urethra) and the other cases in the upper urinary tract (renal calyx, renal pelvis and ureter). Compared with lower urothelial carcinoma, the understanding of upper urothelial carcinoma is not comprehensive, especially the choice of surgical treatment. The surgical treatment of upper tract urothelial carcinoma (UTUC) includes kidney-conserving surgery for low-grade tumors, radical nephroureterectomy for high-grade tumors and palliative surgery for metastatic tumors were reviewed.

参考文献/References:

[1]Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019[J]. CA Cancer J Clin, 2019,69(1):7-34.
[2]Gontero P, Comperat E, Sylvester RJ, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update[J]. Eur Urol, 2018,73(1):111-122.
[3]Xylinas E, Scherr DS, Karakiewicz PI, et al. Urothelial carcinoma of the bladder and the upper tract: Disparate twins[J]. J Urol, 2013,189(4):1214-1221.
[4]程文, 高建平, 张征宇, 等. Ⅱ级膀胱尿路上皮癌microRNA差异表达及意义[J]. 医学研究生学报, 2010,23(1):48-52.
[5]王锋, 杨勇涛. 尿路上皮癌胚抗原1在肿瘤中作用的研究进展[J]. 医学研究生学报, 2018,31(2):204-209.
[6]Bajorin DF, Iyer G, Kim PH, et al. Genomic Characterization of Upper Tract Urothelial Carcinoma[J]. Eur Urol, 2015,68(6):970-977.
[7]Seisen T, Peyronnet B, Luis Dominguez-Escrig J, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel[J]. Eur Urol, 2016,70(6):1052-1068.
[8]郝一昌, 陈昆, 刘余庆, 等. 输尿管软镜下钬激光切除术治疗肾盂癌6例报道及文献复习[J]. 北京大学学报（医学版）, 2018,50(5):816-821.
[9]明少雄, 彭泳涵, 李凌, 等. 输尿管软镜联合铥激光治疗上尿路尿路上皮癌的初步经验[J]. 中华泌尿外科杂志, 2019,40(9):650-653.
[10]郝一昌, 肖春雷, 刘可, 等. 窄带成像技术结合输尿管软镜在上尿路尿路上皮肿瘤诊断、治疗和随访中的应用研究[J]. 中华外科杂志, 2018,56(3):222-226.
[11]Osman E, Alnaib Z, Kumar N. Photodynamic diagnosis in upper urinary tract urothelial carcinoma: A systematic review[J]. Arab J Urol, 2017,15(2):100-109.
[12]Freund JE, Faber DJ, Bus MT, et al. Grading upper tract urothelial carcinoma with the attenuation coefficient of in-vivo optical coherence tomography[J]. Lasers Surg Med, 2019, doi: 10.1002/lsm.23079.
[13]Balaà J, Territo A, Gallioli A, et al. Confocal laser endomicroscopy for the treatment of upper urinary tract transitional cellcarcinoma[J]. Arch Esp Urol, 2019,72(8):765-771.
[14]Seisen T, Peyronnet B, Dominguez-Escrig JL, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel[J]. Eur Urol, 2016,70(6):1052-1068.
[15]Veccia A, Antonelli A, Checcucci E, et al. Segmental Ureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review and Meta-analysis of Comparative Studies[J]. Clin Genitourin Cancer, 2020,8(1):e10-e20.
[16]刘康, 周克冲, 宋宇轩, 等. 比较腹腔镜与开放手术治疗上尿路尿路上皮癌预后的Meta分析[J]. 临床泌尿外科杂志, 2019,34(2):113-118.
[17]Peyronnet B, Seisen T, Dominguez-Escrig JL, et al. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review[J]. Eur Urol Focus, 2019,5(2):205-223.
[18]张征宇, 高建平, 葛京平, 等. 后腹腔镜下肾输尿管全长及经尿道膀胱袖状切除术治疗上尿路癌[J]. 医学研究生学报, 2010,23(2):181-183.
[19]吴进锋, 林榕城, 林友成, 等. 肾输尿管全长切除术两种不同术式的双中心疗效对比[J]. 北京大学学报(医学版), 2019,51(4):646-652.
[20]Giannakopoulos S, Toufas G, Dimitriadis C, et al. Laparoscopic Transvesical Resection of an En Bloc Bladder Cuff and Distal Ureter during Nephroureterectomy[J].Sci World J, 2012, 2012:658096.
[21]马潞林, 黄毅, 卢剑, 等. 后腹腔镜下肾输尿管全长及膀胱袖状切除术35例报告[J]. 中华泌尿外科杂志, 2006(7):450-452.
[22]Lee SM, McKay A, Grimes N, et al. Distal Ureter Management During Nephroureterectomy: Evidence from a Systematic Review and Cumulative Analysis[J]. J Endourol, 2019,33(4):263-273.
[23]Matsunaga T, Komura K, Hashimoto T, et al. Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohort[J]. World J Urol, 2020.
[24]Gregg RW, Vera-Badillo FE, Booth CM, et al. Perioperative chemotherapy for urothelial carcinoma of the upper urinary tract: A systematic review and meta-analysis[J]. Crit Rev Oncol Hematol, 2018,128:58-64.
[25]Chakiryan N, Martinez A, Gao L, et al. Optimizing the Sequence of Chemotherapy for Upper Tract Urothelial Carcinoma with Clinically Positive Regional Lymph Nodes[J].J Urol, 2019,202(1):76-82.
[26]Jazayeri SB, Liu JS, Weissman B, et al. Comparison of Adjuvant Chemotherapy for Upper Tract versus Lower Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis[J].Curr Urol, 2019,12(4):177-187.
[27]Nazzani S, Mazzone E, Preisser F, et al. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma[J].Eur J Surg Oncol, 2019,45(7):1238-1245.
[28]Kondo T, Takagi T, Tanabe K. Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract[J]. World J Clin Oncol, 2015,6(6):237-251.
[29]Dominguez-Escrig JL, Peyronnet B, Seisen T, et al. Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer[J]. Eur Urol Focus, 2019,5(2):224-241.
[30]Zhai TS, Jin L, Zhou Z, et al. Effect of lymph node dissection on stage-specific survival in patients with upper urinary tract urothelial carcinoma treated with nephroureterectomy[J].BMC Cancer, 2019,19(1):1207.
[31]Grimes N, McKay A, Lee SM, et al. Lymph node dissection during nephroureterectomy: Establishing the existing evidence based on a review of the literature[J]. Arab J Urol, 2019,17(3):167-180.
[32]Dong F, Xu T, Wang X, et al. Lymph node dissection could bring survival benefits to patients diagnosed with clinically node-negative upper urinary tract urothelial cancer: a population-based, propensity score-matched study[J]. Int J Clin Oncol, 2019,24(3):296-305.
[33]Seisen T, Jindal T, Karabon P, et al. Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma[J].Eur Urol, 2017,71(5):714-718.

相似文献/References:

[1]冷冬妮,刘 志,刘英娜,等.膀胱尿路上皮癌伴腺性分化临床病理观察[J].医学研究与战创伤救治(原医学研究生学报),2011,13(06):512.
　LENG Dong-ni,LIU Zhi,LIU Ying-na,et al.Clinicopathological observation of urothelial carcinoma of the bladder with glandular differentiation[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2011,13(4):512.

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2020-07-13